52 related articles for article (PubMed ID: 34919530)
1. In-hospital outcomes of septal myectomy vs. alcohol septal ablation for hypertrophic cardiomyopathy with outflow tract obstruction: An update and insights from the national inpatient sample from 2011 to 2019.
Inestroza K; Mijares-Rojas I; Matute-Martínez C; Ergui I; Albosta M; Vergara-Sanchez C; Dangl M; Hernandez RJ; Ebner B; Vincent LT; Maning J; Alfonso C; Colombo R
J Investig Med; 2024 Mar; 72(3):262-269. PubMed ID: 38185664
[TBL] [Abstract][Full Text] [Related]
2. Gender-Based Outcome Discrepancies in Patients Who Underwent Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy: A Systematic Review and Meta-Analysis.
Saravanabavanandan R; Jaimalani A; Khan MAN; Riaz S; Mangas GM; Ahsan SM; Posani S; Patel T; Fawad M; Al-Tawil M
Am J Cardiol; 2023 Dec; 208():134-142. PubMed ID: 37839170
[TBL] [Abstract][Full Text] [Related]
3. Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy.
Altibi AM; Sapru A; Ghanem F; Zhao Y; Alani A; Cigarroa J; Nazer B; Song HK; Masri A
Int J Cardiol; 2024 Apr; 400():131790. PubMed ID: 38242508
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Effectiveness of Alcohol Septal Ablation Versus Ventricular Septal Myectomy on Acute Care Use for Cardiovascular Disease in Patients With Hypertrophic Cardiomyopathy.
Shimada YJ; Goto T; Takayama H; Brown DFM; Homma S; Maurer MS; Reilly MP; Hasegawa K
Am J Cardiol; 2019 Oct; 124(8):1272-1278. PubMed ID: 31447010
[TBL] [Abstract][Full Text] [Related]
5. Treatment Strategies for Hypertrophic Cardiomyopathy: Alcohol Septal Ablation and Procedural Step-by-Step Technique.
Bali AD; Malik A; Naidu SS
Am J Cardiol; 2024 Feb; 212S():S42-S52. PubMed ID: 38368036
[TBL] [Abstract][Full Text] [Related]
6. Sex-Related Differences in Patients With Hypertrophic Cardiomyopathy Undergoing Alcohol Septal Ablation.
Alabdaljabar MS; Elhadi M; Geske JB; Klarich KW; Guerrero M; Eleid MF
J Am Heart Assoc; 2024 May; 13(9):e032553. PubMed ID: 38700034
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Clinical Outcome After Alcohol Septal Ablation and Its Periprocedural Predictive Factors in Japan - A Retrospective Observational Study.
Sawayama Y; Kubo S; Ohya M; Ono S; Tanaka H; Maruo T; Nakagawa Y; Kadota K
Circ J; 2023 Dec; 88(1):127-132. PubMed ID: 37899174
[TBL] [Abstract][Full Text] [Related]
8. Impact of Hospital Volume on Outcomes of Septal Myectomy for Hypertrophic Cardiomyopathy.
Holst KA; Schaff HV; Smedira NG; Habermann EB; Day CN; Badhwar V; Takayama H; McCarthy PM; Dearani JA
Ann Thorac Surg; 2022 Dec; 114(6):2131-2138. PubMed ID: 35779600
[TBL] [Abstract][Full Text] [Related]
9. Healthcare resource utilization and cost of obstructive hypertrophic cardiomyopathy in a US population.
Butzner M; Maron M; Sarocco P; Teng CC; Stanek E; Tan H; Robertson L
Am Heart J Plus; 2022 Jan; 13():100089. PubMed ID: 38560082
[TBL] [Abstract][Full Text] [Related]
10. Age-Based Outcomes in Patients Who Underwent Septal Reduction Therapy.
Ashraf M; Jan MF; Jahangir A; Tajik AJ
Am J Cardiol; 2023 Oct; 205():338-345. PubMed ID: 37634400
[TBL] [Abstract][Full Text] [Related]
11. Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM).
Almeida DR
Arq Bras Cardiol; 2019 Apr; 112(4):439-440. PubMed ID: 30994723
[No Abstract] [Full Text] [Related]
12. Impact of Blood Culture Contamination on Antibiotic Use, Resource Utilization, and Clinical Outcomes: A Retrospective Cohort Study in Dutch and US Hospitals.
Schinkel M; Boerman A; Carroll K; Cosgrove SE; Hsu YJ; Klein E; Nanayakkara P; Schade R; Wiersinga WJ; Fabre V
Open Forum Infect Dis; 2024 Feb; 11(2):ofad644. PubMed ID: 38312218
[TBL] [Abstract][Full Text] [Related]
13. Cerclage Septal Ablation for Hypertrophic Cardiomyopathy: Will a Backdoor Attack on the Septum Be Better?
Bach RG
JACC Basic Transl Sci; 2020 Oct; 5(10):999-1001. PubMed ID: 33165336
[TBL] [Abstract][Full Text] [Related]
14. Favorable Long-Term Outcomes After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in Japan.
Tokita Y; Matsuda J; Imori Y
Circ J; 2023 Dec; 88(1):133-134. PubMed ID: 38057102
[No Abstract] [Full Text] [Related]
15. Mortality After Alcohol Septal Ablation vs. Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.
Yasuda R; Osawa I; Goto T; Hasegawa K; Fifer MA; Tower-Rader A; Reilly MP; Maurer MS; Zhao Y; Takayama H; Shimada YJ
Circ Rep; 2024 Mar; 6(3):74-79. PubMed ID: 38464986
[No Abstract] [Full Text] [Related]
16. A Narrative Review of Emerging Therapies for Hypertrophic Obstructive Cardiomyopathy.
da Silva Menezes Junior A; de Oliveira ALV; Maia TA; Botelho SM
Curr Cardiol Rev; 2023; 19(4):e240323214927. PubMed ID: 36999417
[TBL] [Abstract][Full Text] [Related]
17. Differences in Short-Term Outcomes and Hospital-Based Resource Utilization Between Septal Reduction Strategies for Hypertrophic Obstructive Cardiomyopathy.
Yandrapalli S; Harikrishnan P; Andries G; Aronow WS; Panza JA; Naidu SS
J Invasive Cardiol; 2022 Jan; 34(1):E8-E13. PubMed ID: 34919530
[TBL] [Abstract][Full Text] [Related]
18. Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011.
Kim LK; Swaminathan RV; Looser P; Minutello RM; Wong SC; Bergman G; Naidu SS; Gade CL; Charitakis K; Singh HS; Feldman DN
JAMA Cardiol; 2016 Jun; 1(3):324-32. PubMed ID: 27438114
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
